The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Therapeutic aspects of cannabis and cannabinoids
Open accessAbstract
Background: Review commissioned in 1996 by the Department of Health (DOH). Aims: Assess therapeutic profile of cannabis and cannabinoids. Method: Medline search, references supplied by DOH and others, and personal communications. Results and Conclusions: Cannabis and some cannabinoids are effective antiemetics and analgesics and reduce intraocular pressure. There is evidence of symptom relief and improved well-being in selected neurological conditions, AIDS and certain cancers. Cannabinoids may reduce anxiety and improve sleep. Anticonvulsant activity requires clarification. Other properties identified by basic research await evaluation. Standard treatments for many relevant disorders are unsatisfactory. Cannabis is safe in overdose but often produces unwanted effects, typically sedation, intoxication, clumsiness, dizziness, dry mouth, lowered blood pressure or increased heart rate. The discovery of specific receptors and natural ligands may lead to drug developments. Research is needed to optimise dose and route of administration, quantify therapeutic and adverse effects, and examine interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DISEASES OF THE NERVOUS SYSTEM
JELLIFFE, S. E., & WHITE, W. A. (1918) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191803000-00015 · Cited by 1,277
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 568
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504
Marijuana and medicine: assessing the science base
(1999) · Choice Reviews Online · doi:10.5860/choice.37-2206 · Cited by 410
Pertwee, R. G. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90080-x · Cited by 382
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364
The Perceived Effects of Smoked Cannabis on Patients with Multiple Sclerosis
Consroe, P., Musty, R., Rein, J., Tillery, W., & Pertwee, R. (1997) · European Neurology · doi:10.1159/000112901 · Cited by 323
Controlled clinical trial of cannabidiol in Huntington's disease
Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., & Schram, K. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90386-g · Cited by 320
Cannabinoids as Therapeutic Agents
(2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667 · Cited by 311
Hypnotic and Antiepileptic Effects of Cannabidiol
CARLINI, E. A., & CUNHA, J. M. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02622.x · Cited by 277
Analgesic Effect of Delta‐9‐Tetrahydrocannabinol
NOYES, R., BRUNK, S. F., BARAM, D. A., & CANTER, A. (1975) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1975.tb02348.x · Cited by 273
CHANG, A. E., SHILING, D. J., STILLMAN, R. C., GOLDBERG, N. H., SEIPP, C. A., BAROFSKY, I., SIMON, R. M., & ROSENBERG, S. A. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-819 · Cited by 259
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Grinspoon, L. (1969) · Scientific American · doi:10.1038/scientificamerican1269-17 · Cited by 209
Clinical Relevance of Cannabis Tolerance and Dependence
JONES, R. T., BENOWITZ, N. L., & HERNING, R. I. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02589.x · Cited by 191
Effect of Marihuana on Intraocular and Blood Pressure in Glaucoma
Merritt, J. C., Crawford, W. J., Alexander, P. C., Anduze, A. L., & Gelbart, S. S. (1980) · Ophthalmology · doi:10.1016/s0161-6420(80)35258-5 · Cited by 184
An efficient new cannabinoid antiemetic in pediatric oncology
Abrahamov, A., Abrahamov, A., & Mechoulam, R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00194-b · Cited by 182
Behavioral analysis of marijuana effects on food intake in humans
Foltin, R. W., Brady, J. V., & Fischman, M. W. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90144-9 · Cited by 176
Tetrahydrocannabinol for tremor in multiple sclerosis
Clifford, D. B. (1983) · Annals of Neurology · doi:10.1002/ana.410130616 · Cited by 168
Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis
Ungerleider, J. T., Andyrsiak, T., Fairbanks, L., Ellison, G. W., & Myers, L. W. (1988) · Advances in Alcohol & Substance Abuse · doi:10.1300/j251v07n01_04 · Cited by 165
Treatment of Human Spasticity with Δ9‐Tetrahydrocannabinol
Petro, D. J., & Ellenberger, C. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02621.x · Cited by 154
Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain
Jain, A. K., Ryan, J. R., McMahon, F. G., & Smith, G. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02610.x · Cited by 150
Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine
Hollister, L. E. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197112144 · Cited by 144
The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety
FABRE, L. F., & McLENDON, D. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02617.x · Cited by 138
A Double-Blind Trial of ??9-Tetrahydrocannabinol in Primary Anorexia Nervosa
Gross, H. A., Ebert, M. H., Faden, V. B., Goldberg, S. C., Kaye, W. H., Caine, E. D., Hawks, R. L., & Zinberg, N. E. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198306000-00004 · Cited by 133
Pain relief with oral cannabinoids in familial Mediterranean fever
Holdcroft, A., Smith, M., Jacklin, A., Hodgson, H. J. F., Smith, B., Newton, M., & Evans, F. J. (1997) · Anaesthesia · doi:10.1111/j.1365-2044.1997.139-az0132.x · Cited by 129
Greenberg, H. S., Werness, S. A. S., Pugh, J. E., Andrus, R. O., Anderson, D. J., & Domino, E. F. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.33 · Cited by 128
ON THE THERAPEUTICAL USES AND TOXIC EFFECTS OF CANNABIS INDICA.
Reynolds, J. R. (1890) · The Lancet · doi:10.1016/s0140-6736(02)18723-x · Cited by 119
Maurer, M., Henn, V., Dittrich, A., & Hofmann, A. (1990) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190083 · Cited by 117
Anticonvulsant Nature of Marihuana Smoking
Consroe, P. F. (1975) · JAMA · doi:10.1001/jama.1975.03260160054015 · Cited by 110
Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.
Doblin, R., & Kleiman, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1314 · Cited by 108
Nabilone: an alternative antiemetic for cancer chemotherapy.
Dalzell, A. M., Bartlett, H., & Lilleyman, J. S. (1986) · Archives of Disease in Childhood · doi:10.1136/adc.61.5.502 · Cited by 98
Chan, H. S. L., Correia, J., & MacLeod, S. M. (1987) · PEDIATRICS · doi:10.1542/peds.79.6.946 · Cited by 95
Nabilone: An Effective Antiemetic in Patients Receiving Cancer Chemotherapy
Einhorn, L. H., Nagy, C., Furnas, B., & Williams, S. D. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02576.x · Cited by 91
Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects.
Tashkin, D. P., Reiss, S., Shapiro, B. J., Calvarese, B. M., Olsen, J., & Lodge, J. W. (1977) · PubMed · doi:10.1164/arrd.1977.115.1.57 · Cited by 78
Marihuana, the Forbidden Medicine
FINK, M. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1091 · Cited by 77
Thomas, R., & CHESHER, G. B. (1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb128792.x · Cited by 76
Pomeroy, M., FENNELLY, J. J., & Towers, M. J. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00256701 · Cited by 59
Orr, L. E., & Mckernan, J. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02578.x · Cited by 54
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy
Niiranen, A., & Mattson, K. V. (1985) · American Journal of Clinical Oncology · doi:10.1097/00000421-198508000-00013 · Cited by 54
Topical Δ9-tetrahydrocannabinol in hypertensive glaucomas
Merritt, J. C., Olsen, J., Armstrong, J. R., & McKinnon, S. J. (1981) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1981.tb13699.x · Cited by 51
Jones, S. E., Durant, J. R., Greco, F. A., & Robertone, A. B. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80035-2 · Cited by 47
Meyer, J. S., & Connor, R. E. (1982) · Cancer · doi:10.1002/1097-0142(19820815)50:4<636::aid-cncr2820500404>3.0.co;2-4 · Cited by 41
Niederle, N., Schütte, J., & Schmidt, C. G. (1986) · Journal of Molecular Medicine · doi:10.1007/bf01728184 · Cited by 41
Bioavailability of potassium from controlled-release tablets with and without water loading
Bechgaard, H., & Shephard, N. W. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637515 · Cited by 40
The medicinal uses of cannabis and its constituents
Formukong, E. A., EVANS, A. T., & Evans, F. J. (1989) · Phytotherapy Research · doi:10.1002/ptr.2650030602 · Cited by 29
Clinical Trials with Antiemetic Agents in Cancer Patients Receiving Chemotherapy
Penta, J. S., Poster, D. S., Bruno, S., & Macdonald, J. S. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02568.x · Cited by 28
The quasi-morphine withdrawal syndrome: Effect of cannabinol, cannabidiol and tetrahydrocannabinol
CHESHER, G. B., & Jackson, D. M. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90122-4 · Cited by 24
Research works printed but not linked: 9
- Meek C. (1994) Doctors want cannabis prescriptions allowed. BMA News Review, 15 February, p. 15.
- Hall, 1994, The Health and Psychological Consequences of Cannabis
- Pertwee R. G. (1995) Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: an overview. In Cannabinoid Receptors (ed. Pertwee R. ), pp. 1–34. Harcourt Brace.
- Lane, 1991, Dronabinol and prochlorperazine in combination are better than either agent alone for treatment of chemotherapy-induced nausea and vomiting, Proceedings of the American Society of Clinical Oncologists, 8, 326
- Hepler, 1976, The Pharmacology of Marihuana
- 1988, Cannabis: The Scientific and Medical Evidence (HL Paper 151)
- Ilaria, 1981, Nabilone, a cannabinol derivative, in the treatment of anxiety neuroses, Current Therapeutic Research, 29, 943
- Mechoulam, 1986, Cannabinoids as Therapeutic Agents, 1
- Harris, 1976, The Pharmacology of Marihuana, Vol. 2, 749
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Iversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Metadata
- Authors
- Robson, P.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-02
- Volume
- 178
- Issue
- 2
- Pages
- 107-115
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1965534002
- Cited by
- 265
- References
- 50
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.